Article
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.
Science (New York, N.Y.) - 17 Apr 2020
Walton Russell T, Christie Kathleen A, Whittaker Madelynn N, Kleinstiver Benjamin P
Abstract excerpt
Manipulation of DNA by CRISPR-Cas enzymes requires the recognition of a protospacer-adjacent motif (PAM), limiting target site recognition to a subset of sequences. To remove this constraint, we engineered variants of Streptococcus pyogenes Cas9 (SpCas9) to eliminate the NGG PAM requirement. We developed a variant named SpG that is capable of targeting an expanded set of NGN PAMs, and we further optimized this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
